Remove Clinical Trials Remove DEA Remove Legalization Remove Marijuana
article thumbnail

DEA Proposes Dramatic Increase In Marijuana And Psychedelic Production In 2022, Calling For 6,300 Percent More MDMA Alone

Cannabis Law Report

Marijuana Moment report. The Drug Enforcement Administration (DEA) is proposing a dramatic increase in the legal production of marijuana and psychedelics like psilocybin, LSD, MDMA and DMT to be used in research next year. Marijuana itself would get a 60 percent boost under DEA’s proposal, up to 3.2

DEA 96
article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Junk’ cannabis ‘ill-suited for clinical trials’. Shutterstock).

DEA 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Scientists Sue DEA as it Drags its Feet and Hampers Cannabis Research

WeedAdvisor

Drug Enforcement Administration is not a fan of drugs or legalization. Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. A Vicious Circle. .

DEA 111
article thumbnail

Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications

NORML

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. Also on Wednesday, Rep.

DEA 168
article thumbnail

NIDA Monopoly is Over: New DEA-Registered Cannabis Growers Can Supply Researchers with Product

Cannabis Law Report

It seems like every day I read a new story about legislators, high-ranking federal officials, and frustrated advocates of marijuana research complaining that researchers still can’t study the actual marijuana that people are using in the state-legal markets. Use the plants for their own studies and/or FDA clinical trials.

DEA 52
article thumbnail

DEA Seeks to Increase Quota of Cannabis and Psilocybin for Research Purposes

SpeedWeed

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. “DEA View original article.

DEA 52
article thumbnail

NORML “Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions”

Cannabis Law Report

The action represents one of the very few occasions that members of the Senate have ever advanced a marijuana-related reform bill. Under this proposal, the AG is also provided with the ability to authorize increases in the total number of federally approved marijuana cultivators. BILLS-117s253es.